; Diebner, H. H.
; Mayer, P. ; Kondo Ados, A. ; Wahnschaffe, L. ; Braun, T. ; Müller, T. A. ; Wagle, P. ; Bouska, A. ; Neumann, T. ; Pützer, S. ; Varghese, L. ; Pflug, N. ; Thelen, M.
; Makalowski, J. ; Riet, N. ; Göx, H. J. M. ; Rappl, G. ; Altmüller, J. ; Kotrová, M.
; Persigehl, T. ; Hopfinger, G. ; Hansmann, M. L. ; Schlößer, H. ; Stilgenbauer, S. ; Dürig, J. ; Mougiakakos, D. ; von Bergwelt-Baildon, M. ; Roeder, I. ; Hartmann, S. ; Hallek, M. ; Moriggl, R. ; Brüggemann, M. ; Aittokallio, T.
; Iqbal, J. ; Newrzela, S. ; Abken, H. ; Herling, M. | Dokumentenart: | Artikel | ||||
|---|---|---|---|---|---|
| Titel eines Journals oder einer Zeitschrift: | Blood | ||||
| Verlag: | AMER SOC HEMATOLOGY | ||||
| Ort der Veröffentlichung: | WASHINGTON | ||||
| Band: | 136 | ||||
| Nummer des Zeitschriftenheftes oder des Kapitels: | 24 | ||||
| Seitenbereich: | S. 2786-2802 | ||||
| Datum: | 2020 | ||||
| Institutionen: | Leibniz-Institut für Immuntherapie (LIT) | ||||
| Identifikationsnummer: |
| ||||
| Stichwörter / Keywords: | PROLYMPHOCYTIC LEUKEMIA; EXPRESSION; LYMPHOMA; DIFFERENTIATION; IDENTIFICATION; PATTERNS; | ||||
| Dewey-Dezimal-Klassifikation: | 600 Technik, Medizin, angewandte Wissenschaften > 610 Medizin | ||||
| Status: | Veröffentlicht | ||||
| Begutachtet: | Ja, diese Version wurde begutachtet | ||||
| An der Universität Regensburg entstanden: | Ja | ||||
| Dokumenten-ID: | 49436 |
Zusammenfassung
T-cell prolymphocytic leukemia (T-PLL) is a poor-prognostic neoplasm. Differentiation stage and immune-effector functions of the underlying tumor cell are insufficiently characterized. Constitutive activation of the T-cell leukemia 1A (TCL1A) oncogene distinguishes the (pre) leukemic cell from regular postthymic T cells. We assessed activation-response patterns of the T-PLL lymphocyte and ...

Zusammenfassung
T-cell prolymphocytic leukemia (T-PLL) is a poor-prognostic neoplasm. Differentiation stage and immune-effector functions of the underlying tumor cell are insufficiently characterized. Constitutive activation of the T-cell leukemia 1A (TCL1A) oncogene distinguishes the (pre) leukemic cell from regular postthymic T cells. We assessed activation-response patterns of the T-PLL lymphocyte and interrogated the modulatory impact by TCL1A. Immunophenotypic and gene expression profiles revealed a unique spectrum of memory-type differentiation of T-PLL with predominant central-memory stages and frequent noncanonical patterns. Virtually all T-PLL expressed a T-cell receptor (TCR) and/or CD28-coreceptor without overrepresentation of specific TCR clonotypes. The highly activated leukemic cells also revealed losses of negative regulatory TCR coreceptors (eg, CTLA4). TCR stimulation of T-PLL cells evoked higher-than normal cell-cycle transition and profiles of cytokine release that resembled those of normal memory T cells. More activated phenotypes and higher TCL1A correlated with inferior clinical outcomes. TCL1A was linked to the marked resistance of T-PLL to activationand FAS-induced cell death. Enforced TCL1A enhanced phospho-activation of TCR kinases, second-messenger generation, and JAK/STAT or NFAT transcriptional responses. This reduced the input thresholds for IL-2 secretion in a sensitizer-like fashion. Mice of TCL1A-initiated protracted T-PLL development resembled such features. When equipped with epitope-defined TCRs or chimeric antigen receptors, these Lckpr-hTCL1AtgT cells gained a leukemogenic growth advantage in scenarios of receptor stimulation. Overall, we propose a model of T-PLL pathogenesis in which TCL1A enhances TCR signals and drives the accumulation of death-resistant memory-type cells that use amplified low-level stimulatory input, and whose loss of negative coregulators additionally maintains their activated state. Treatment rationales are provided by combined interception in TCR and survival signaling.
Metadaten zuletzt geändert: 11 Okt 2021 12:35
Altmetric